US Patent Issued to IMMATICS BIOTECHNOLOGIES on Nov. 11 for "Peptides and combination of peptides for use in immunotherapy against cancers" (German Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,878, issued on Nov. 11, was assigned to IMMATICS BIOTECHNOLOGIES GMBH (Tubingen, Germany).

"Peptides and combination of peptides for use in immunotherapy against cancers" was invented by Toni Weinschenk (Tuebingen, Germany), Oliver Schoor (Tuebingen, Germany) and Andrea Mahr (Tuebingen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present description relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present description relates to the immunotherapy of cancer. The present description further relates to tumor-associated T-cell peptide epitopes, alone or in combination with othe...